Hepatotoxicity Associated with the Use of Anti-TNF-α Agents

about

Drug-Induced Liver Injury: Highlights from a Review of the 2015 Literature.Liver Illness and Psoriatic Patients.

P2860

Q38824550-415A9226-36E4-4278-8DA5-1327564EEB5B Q54254957-8352760A-C367-4CF3-B7B0-D9B215E37F7C

P2860

Hepatotoxicity Associated with the Use of Anti-TNF-α Agents

Item

http://www.wikidata.org/entity/Q36576535

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Hepatotoxicity Associated with the Use of Anti-TNF-α Agents

@ast

Hepatotoxicity Associated with the Use of Anti-TNF-α Agents

@en

type

Item

label

Hepatotoxicity Associated with the Use of Anti-TNF-α Agents

@ast

Hepatotoxicity Associated with the Use of Anti-TNF-α Agents

@en

prefLabel

Hepatotoxicity Associated with the Use of Anti-TNF-α Agents

@ast

Hepatotoxicity Associated with the Use of Anti-TNF-α Agents

@en

P1476

Hepatotoxicity Associated with the Use of Anti-TNF-α Agents

@en

P2093

David Foureau

http://www.w3.org/2001/XMLSchema#string

Herbert L Bonkovsky

http://www.w3.org/2001/XMLSchema#string

Joshua B French

http://www.w3.org/2001/XMLSchema#string

Marwan Ghabril

http://www.w3.org/2001/XMLSchema#string

Maurizio Bonacini

http://www.w3.org/2001/XMLSchema#string

P2860

An endotoxin-induced serum factor that causes necrosis of tumors

Liver injury from tumor necrosis factor-α antagonists: analysis of thirty-four cases

Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey

Tumour necrosis factor-alpha inhibitor-induced hepatic injury in patients with rheumatoid arthritis: two case reports and an analysis of the laboratory data from the Slovenian national biologicals registry.

Transmembrane TNF-alpha: structure, function and interaction with anti-TNF agents.

The immunogenicity of humanized and fully human antibodies: residual immunogenicity resides in the CDR regions

Utilization trends of anti-TNF agents and health outcomes in adults and children with inflammatory bowel diseases: a single-center experience.

The saga of the discovery of IL-1 and TNF and their specific inhibitors in the pathogenesis and treatment of rheumatoid arthritis.

Adverse events of anti-tumor necrosis factor α therapy in ankylosing spondylitis

Alopecia secondary to anti-tumor necrosis factor-alpha therapy

P2888

s40264-015-0366-9

P304

199-208

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40264-015-0366-9

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26692395

http://www.w3.org/2001/XMLSchema#string

P921

hepatotoxicity

TNF inhibitor

P932

4752395

http://www.w3.org/2001/XMLSchema#string

Hepatotoxicity Associated with the Use of Anti-TNF-α Agents

about

P2860

P2860

Hepatotoxicity Associated with the Use of Anti-TNF-α Agents

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932